PortfoliosLab logoPortfoliosLab logo
WVE vs. GRAB
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

WVE vs. GRAB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Wave Life Sciences Ltd. (WVE) and Grab Holdings Limited (GRAB). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, WVE achieves a -66.47% return, which is significantly lower than GRAB's -33.27% return.


WVE

1D
-0.52%
1M
-20.61%
YTD
-66.47%
6M
-69.22%
1Y
-21.05%
3Y*
11.70%
5Y*
-4.83%
10Y*
-9.83%

GRAB

1D
-0.30%
1M
-10.48%
YTD
-33.27%
6M
-35.47%
1Y
-35.59%
3Y*
-1.08%
5Y*
-21.98%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

WVE vs. GRAB - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
WVE
Wave Life Sciences Ltd.
-66.47%37.43%144.95%-27.86%122.93%-60.10%-12.07%
GRAB
Grab Holdings Limited
-33.27%5.72%40.06%4.66%-54.84%-44.56%8.16%

Correlation

The correlation between WVE and GRAB is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.17

Correlation (3Y)
Calculated over the trailing 3-year period

0.22

Correlation (5Y)
Calculated over the trailing 5-year period

0.19

Correlation (All Time)
Calculated using the full available price history since Dec 2, 2020

0.18

Fundamentals

Market Cap

WVE:

$1.14B

GRAB:

$14.79B

EPS

WVE:

-$1.03

GRAB:

$0.09

PS Ratio

WVE:

14.13

GRAB:

4.05

PB Ratio

WVE:

2.23

GRAB:

2.27

Total Revenue (TTM)

WVE:

$71.80M

GRAB:

$3.55B

Gross Profit (TTM)

WVE:

$29.09M

GRAB:

$1.55B

EBITDA (TTM)

WVE:

-$184.40M

GRAB:

$481.00M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

WVE vs. GRAB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WVE
WVE Risk / Return Rank: 4444
Overall Rank
WVE Sharpe Ratio Rank: 3737
Sharpe Ratio Rank
WVE Sortino Ratio Rank: 5757
Sortino Ratio Rank
WVE Omega Ratio Rank: 6262
Omega Ratio Rank
WVE Calmar Ratio Rank: 3333
Calmar Ratio Rank
WVE Martin Ratio Rank: 3232
Martin Ratio Rank

GRAB
GRAB Risk / Return Rank: 1010
Overall Rank
GRAB Sharpe Ratio Rank: 66
Sharpe Ratio Rank
GRAB Sortino Ratio Rank: 88
Sortino Ratio Rank
GRAB Omega Ratio Rank: 1010
Omega Ratio Rank
GRAB Calmar Ratio Rank: 1414
Calmar Ratio Rank
GRAB Martin Ratio Rank: 1010
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WVE vs. GRAB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Wave Life Sciences Ltd. (WVE) and Grab Holdings Limited (GRAB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


WVEGRABDifference
Sharpe ratioReturn per unit of total volatility

+0.81

Sortino ratioReturn per unit of downside risk

+2.41

Omega ratioGain probability vs. loss probability

1.17

0.86

+0.31

Calmar ratioReturn relative to maximum drawdown

-0.29

-0.74

+0.45

Martin ratioReturn relative to average drawdown

-0.55

-1.34

+0.79

WVE vs. GRAB - Sharpe Ratio Comparison

The current WVE Sharpe Ratio is -0.13, which is higher than the GRAB Sharpe Ratio of -0.93. The chart below compares the historical Sharpe Ratios of WVE and GRAB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


WVEGRABDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.13

-0.93

+0.81

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.04

-0.37

+0.33

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.10

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.09

-0.34

+0.25

Drawdowns

WVE vs. GRAB - Drawdown Comparison

The maximum WVE drawdown since its inception was -97.77%, which is greater than GRAB's maximum drawdown of -86.46%. Use the drawdown chart below to compare losses from any high point for WVE and GRAB.


Loading charts...

Drawdown Indicators


WVEGRABDifference

Max Drawdown

Largest peak-to-trough decline

-97.77%

-86.46%

-11.31%

Max Drawdown (1Y)

Largest decline over 1 year

-73.30%

-48.37%

-24.93%

Max Drawdown (3Y)

Largest decline over 3 years

-73.30%

-48.37%

-24.93%

Max Drawdown (5Y)

Largest decline over 5 years

-83.53%

-86.46%

+2.93%

Max Drawdown (10Y)

Largest decline over 10 years

-97.77%

Current Drawdown

Current decline from peak

-89.67%

-80.48%

-9.19%

Average Drawdown

Average peak-to-trough decline

-64.78%

-67.35%

+2.57%

Ulcer Index

Depth and duration of drawdowns from previous peaks

38.35%

26.72%

+11.63%

Volatility

WVE vs. GRAB - Volatility Comparison

Wave Life Sciences Ltd. (WVE) has a higher volatility of 16.60% compared to Grab Holdings Limited (GRAB) at 8.61%. This indicates that WVE's price experiences larger fluctuations and is considered to be riskier than GRAB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


WVEGRABDifference

Volatility (1M)

Calculated over the trailing 1-month period

16.60%

8.61%

+7.99%

Volatility (6M)

Calculated over the trailing 6-month period

123.11%

24.40%

+98.71%

Volatility (1Y)

Calculated over the trailing 1-year period

169.12%

38.39%

+130.73%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

114.62%

59.86%

+54.76%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

99.03%

60.53%

+38.50%

Dividends

WVE vs. GRAB - Dividend Comparison

Neither WVE nor GRAB has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

WVE vs. GRAB - Financials Comparison

This section allows you to compare key financial metrics between Wave Life Sciences Ltd. and Grab Holdings Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M1.00B20222023202420252026
38.25M
955.00M
(WVE) Total Revenue
(GRAB) Total Revenue
Values in USD except per share items

WVE vs. GRAB - Profitability Comparison

The chart below illustrates the profitability comparison between Wave Life Sciences Ltd. and Grab Holdings Limited over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-50.0%0.0%50.0%100.0%202220232024202520260
43.4%
Portfolio components
WVE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Wave Life Sciences Ltd. reported a gross profit of 0.00 and revenue of 38.25M. Therefore, the gross margin over that period was 0.0%.

GRAB - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Grab Holdings Limited reported a gross profit of 414.00M and revenue of 955.00M. Therefore, the gross margin over that period was 43.4%.

WVE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Wave Life Sciences Ltd. reported an operating income of -31.30M and revenue of 38.25M, resulting in an operating margin of -81.8%.

GRAB - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Grab Holdings Limited reported an operating income of 75.00M and revenue of 955.00M, resulting in an operating margin of 7.9%.

WVE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Wave Life Sciences Ltd. reported a net income of -26.09M and revenue of 38.25M, resulting in a net margin of -68.2%.

GRAB - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Grab Holdings Limited reported a net income of 136.00M and revenue of 955.00M, resulting in a net margin of 14.2%.


Frequently Asked Questions


WVE and GRAB have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

WVE has higher volatility (16.60%) compared to GRAB (8.61%). In terms of maximum drawdown, WVE dropped -97.77% vs GRAB's -86.46%.

WVE currently has the higher Sharpe Ratio (-0.13 vs -0.93), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for WVE and GRAB

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer